Significant change:Addition of therapeutic indications: Oestrus ovis (L1, L2, L3) in Sheep and Goats, and Przhevalskiana silenus (L1, L2, L3) in Goats. Addition/revision of prudent use recommendations in "Special warnings for each target species" section. Updates to Pharmacokinetics information for goats.
Date:2022-09-30
Scope:Public